Publications by authors named "Filip Josephson"

Claim this Profile
E
Expedited Approval in Oncology: A Study of European Regulators' Perspectives and Trade-Offs.
Francesco Pignatti, Filip Josephson, Pierre Demolis, Olli Tenhunen, Elias Péan

Clin Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia.
Julio Delgado, Filip Josephson, Jorge Camarero, Blanca Garcia-Ochoa, Lucia Lopez-Anglada

Oncologist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma.
Sahra Ali, Jorge Camarero, Paulavan Hennik, Bjorg Bolstad, Maja Sommerfelt Grønvold, Filip Josephson

ESMO Open· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects.
Luca Moscetti, Paula Hennik, Bjorg Bolstad, Jorge Camarero, Filip Josephson

ESMO Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors.
Dominik Karres, Sahra Ali, Paula B van Hennik, Sabine Straus, Filip Josephson

Oncologist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.
Sahra Ali, Alexandre Moreau, Daniela Melchiorri, Jorge Camarero, Filip Josephson

Oncologist· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.
Roy F Chemaly, Sunwen Chou, Hermann Einsele, Paul Griffiths, Robin Avery, Filip Josephson

Clin Infect Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus.
Ryan Taylor Anderson, Seng Gee Lim, Poonam Mishra, Filip Josephson, Eric Donaldson

Gastroenterology· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.
Per Ljungman, Michael Boeckh, Hans H Hirsch, Filip Josephson, Jens Lundgren

Clin Infect Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral treatment for HIV infection: Swedish recommendations 2016.
Jaran Eriksen, Jan Albert, Anders Blaxhult, Christina Carlander, Leo Flamholc, Filip Josephson

Infect Dis (Lond)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations.
Martin Lagging, Rune Wejstål, Gunnar Norkrans, Olle Karlström, Soo Aleman, Filip Josephson

Infect Dis (Lond)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of HIV transmission from patients on antiretroviral therapy: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.
Jan Albert, Torsten Berglund, Magnus Gisslén, Peter Gröön, Anders Sönnerborg, Filip Josephson

Scand J Infect Dis· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013.
Lars Navér, Jan Albert, Ylva Böttiger, Christina Carlander, Leo Flamholc, Filip Josephson

Scand J Infect Dis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations.
Martin Lagging, Ann-Sofi Duberg, Rune Wejstål, Ola Weiland, Magnus Lindh, Filip Josephson

Scand J Infect Dis· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel clinical trial designs for the development of new antiretroviral agents.
Nina Mani, Jeffrey Murray, Roy M Gulick, Filip Josephson, Veronica Miller

AIDS· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2010.
Lars Navér, Jan Albert, Erik Belfrage, Leo Flamholc, Magnus Gisslén, Filip Josephson

Scand J Infect Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients.
Arvid Edén, Lars-Magnus Andersson, Orjan Andersson, Leo Flamholc, Filip Josephson

AIDS Res Hum Retroviruses· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients.
Filip Josephson, Maria C H Andersson, Leo Flamholc, Magnus Gisslén, Lars Hagberg

Eur J Clin Pharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of HIV infection: Swedish recommendations 2009.
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström

Scand J Infect Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations.
Martin Lagging, Rune Wejstål, Ingrid Uhnoo, Barbro Gerdén, Björn Fischler, Filip Josephson

Scand J Infect Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2007.
Lars Navér, Ann-Britt Bohlin, Jan Albert, Leo Flamholc, Magnus Gisslén, Filip Josephson

Scand J Infect Dis· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Insufficient documentation on antitussive agents].
Marine Andersson, Filip Josephson

Lakartidningen· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Green tea can reduce the effect of Waran].
Fadiea Al-Aieshy, Filip Josephson

Lakartidningen· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Vitamin D supplementation to breast feeding mothers not dangerous for the child].
Linda Björkhem Bergman, Filip Josephson

Lakartidningen· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral treatment of HIV infection: Swedish recommendations 2007.
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström

Scand J Infect Dis· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis